serdolect 4 mg film-coated tablets 4 milligram film coated tablet
h. lundbeck a/s - sertindole - film coated tablet - 4 milligram
serdolect 12 mg film-coated tablets
h. lundbeck a/s - sertindole - film coated tablet - 12 milligram
serdolect 16 mg film-coated tablets
h. lundbeck a/s - sertindole - film coated tablet - 16 milligram
serdolect 20 mg film-coated tablets
h. lundbeck a/s - sertindole - film coated tablet - 20 milligram
serdolect 4 mg film-coated tablets
h. lundbeck a/s - sertindole - film coated tablet - 4 milligram
stalevo 125/31.25/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle
sandoz pty ltd - levodopa, quantity: 125 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 33.8 mg (equivalent: carbidopa, qty 31.25 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.
stalevo 75/18.75/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle
sandoz pty ltd - levodopa, quantity: 75 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.
stalevo 200/50/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle
sandoz pty ltd - levodopa, quantity: 200 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 54.1 mg (equivalent: carbidopa, qty 50 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.
stalevo 150/37.5/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle
sandoz pty ltd - levodopa, quantity: 150 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 40.5 mg (equivalent: carbidopa, qty 37.5 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide; iron oxide yellow - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.
stalevo 100/25/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle
sandoz pty ltd - levodopa, quantity: 100 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide; iron oxide yellow - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.